Treatment of Chronic Intractable Neuropathetic Pain with Dronabinol: Case Report of Two Adolescents
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To evaluate the effectiveness of dronabinol for the treatment of neuropathic pain refractory to previous treatment. METHODS: We studied the response (reduction of pain intensity and functional improvement) to dronabinol (5 mg/day to 25 mg/day) in two adolescents with neuropathic pain and depression refractory to previous treatments over two and five years, respectively. RESULTS: Reduction in pain intensity (45%) was achieved in patient 2 and was unchanged in patient 1. Functional improvement was markedly increased in terms of academic performance, mood and sleep in both patients over four to five months, without major adverse effects. While these improvements dissipated over time, the patients were more reconnected with rehabilitation and focused less on the intrusiveness of their pain problem in their every day lives. CONCLUSIONS: Dronabinol appeared to be effective in improving pain affect and psychosocial functioning in the treatment of refractory neuropathic pain and may be considered as an adjuvant medication in the rehabilitation process. Well‐controlled placebo studies are required for further evaluation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Psychological and neural mechanisms of the affective dimension of pain
Price, D. D. (2000) · Science · doi:10.1126/science.288.5472.1769 · Cited by 2,092 · cited 1×
“Psychophysical and brain imaging studies demonstrate that pain sensation and pain unpleasantness are two distinct dimension of pain that are located in specific areas of the brain and are separately influenced by various psychological factors (12).”
BackgroundHerzberg, U., Eliav, E., Bennett, G. J., & Kopin, I. J. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13308-5 · Cited by 307 · cited 1×
“Cannabinoids have been proposed for the treatment of chronic pain syndromes resistant to standard therapy (5,6), due to their potent efficacy in suppressing neuropathic pain behaviour and reversal of mechanical hyperalgesia in animal models (7).”
BackgroundPhysical therapy and cognitive-behavioral treatment for complex regional pain syndromes
Lee, B. H., Scharff, L., Sethna, N. F., McCarthy, C. F., Scott-Sutherland, J., Shea, A. M., Sullivan, P., Meier, P., Zurakowski, D., Masek, B. J., et al. (2002) · The Journal of Pediatrics · doi:10.1067/mpd.2002.124380 · Cited by 294 · cited 2×
“For example, one trial employing cognitive behavioural therapy by Lee et al (4) with varying numbers of physiotherapy sessions, showed both treatments reduced pain and disability in children.”
BackgroundCannabis for Chronic Pain: Case Series and Implications for Clinicians
Ware, M. A., Gamsa, A., Persson, J., & Fitzcharles, M.-A. (2002) · Pain Research and Management · doi:10.1155/2002/380509 · Cited by 38
Cited by
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
“…sclerosis, cancer, neuropathies, and HIV infection (Noyes et al., 1975a,b; Martyn et al., 1995; Consroe et al., 1997; Hamann and di Vadi, 1999; Ware et al., 2003; Rudich et al., 2003; Ware and Beaulieu, 2005; Ware et al., 2005; Berlach et al., 2006; reviewed in Burns and Ineck, 2006) (Table 1).”
BackgroundRusso, E., & Guy, G. W. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2005.08.026 · Cited by 610
Black, N., Stockings, E., Campbell, G., Tran, L. T., Zagic, D., Hall, W. D., Farrell, M., & Degenhardt, L. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30401-8 · Cited by 564
Stockings, E., Campbell, G., Hall, W. D., Nielsen, S., Zagic, D., Rahman, R., Murnion, B., Farrell, M., Weier, M., & Degenhardt, L. (2018) · Pain · doi:10.1097/j.pain.0000000000001293 · Cited by 460
Pinsger, M., Schimetta, W., Volc, D., Hiermann, E., Riederer, F., & Pölz, W. (2006) · Wiener klinische Wochenschrift · doi:10.1007/s00508-006-0611-4 · Cited by 96
“Diese bekannten physiologischen Einflüsse des Cannabinoidsystems bilden eine plausible Grundlage für klinische Wirkungen auf verschiedene Schmerzformen, wie neuropathischer Schmerz [16], Pruritus [17], Schmerz und Muskelverkrampfung bei Multipler Sklerose (MS) [14], Migräne, Kopfschmerz und Schmerzen am Bewegungsappar…”
Background
Metadata
- Authors
- Rudich, Z., Stinson, J., Jeavons, M., & Brown, S. C.
- Venue
- Pain Research and Management
- Publisher
- Wiley
- Published
- 2003-01
- Volume
- 8
- Issue
- 4
- Pages
- 221-224
- ISSN
- 1203-6765 (ISSN-L)
- 1918-1523
- OpenAlex
- W123565989
- Cited by
- 29
- References
- 4
- FWCI
- 0.80
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.